Trial Profile
A 5-year follow up study to study heart transplant recipients receiving everolimus plus tacrolimus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 03 Nov 2015 New trial record